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A lack of the REDD1 promotes dysregulated growth signaling, though little has been established with 
respect to the metabolic role of REDD1. PURPOSE: The goal of this study was to determine the role of 
REDD1 on glucose and insulin tolerance, as well as insulin stimulated growth signaling pathway 
activation in skeletal muscle. METHODS: First, intraperitoneal (IP) injection of glucose or insulin were 
administered to REDD1 wildtype (WT) versus knockout (KO) mice to examine changes in blood glucose 
over time. Next, alterations in skeletal muscle insulin (IRS-1, Akt, ERK 1/2) and growth (4E-BP1, S6K1, 
REDD1) signaling intermediates were determined before and after IP insulin treatment (10 min) using 
Western blot analysis. RESULTS: REDD1 KO mice were both glucose and insulin intolerant when 
compared to WT mice, following IP injections of glucose or insulin, respectively. REDD1 KO mice 
exhibited higher (p<0.05) circulating blood glucose concentrations and a greater (p<0.05) area under the 
curve. The REDD1 KO exhibited significant though blunted insulin-stimulated increases (p<0.05) in Akt 
S473 and T308 phosphorylation versus the WT mice. Additionally, acute insulin treatment had no effect 
on 4E-BP1 T37/46, S6K1 T389, IRS-1 Y1222, and ERK 1/2 T202/Y204 phosphorylation in skeletal 
muscle from REDD1 KO versus the WT mice. CONCLUSION: The results provide a deeper 
understanding of REDD1 as it relates to insulin-stimulated mTORC1 signaling, encompassing 
metabolism and insulin action. A lack of REDD1 contributes to glucose and insulin intolerance that is 
associated with dysregulated insulin stimulation of both mTORC1 and ERK1/2 pathways. Collectively, 
these novel data suggest that REDD1 has a more distinct role in whole body and skeletal muscle 
metabolism and insulin action than previously thought. 
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